Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Inhibition of Endothelial Cell Tube Formation by ADAMTS13 Occurs Via Interaction with VEGF

Eva S. Rodansky, PhD, Justin K. Smith, PhD, Hugh J.L. Fryer, PhD, Robert S. Greenfield, George M. Rodgers, MD, PhD

Blood (2010) 116 (21): 4307.

https://doi.org/10.1182/blood.V116.21.4307.4307

Published: 2010

Journal Articles

Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis.

Lawrence T Goodnough, George Despotis, Peter K Smith, Jerrold Levy, MD, Robert Poston, Mary Short, Govinda Weerakkody, LeRoy Lenarz

Blood (2010) 116 (21): 1108.

https://doi.org/10.1182/blood.V116.21.1108.1108

Published: 2010

Journal Articles

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Don M. Benson, Jr, Courtney E. Bakan, Anjali Mishra, Craig C. Hofmeister, Yvonne Efebera, Brian Becknell, Robert A. Baiocchi, Jianying Zhang, Jianhua Yu, Megan K. Smith, Carli N. Greenfield, Pierluigi Porcu, Steven M. Devine, Rinat Rotem-Yehudar, Gerard Lozanski, John C. Byrd, Michael A. Caligiuri

Blood (2010) 116 (13): 2286–2294.

https://doi.org/10.1182/blood-2010-02-271874

Published: 2010

Includes: Supplemental data

Journal Articles

Characterization of Early Natural Killer Cell Reconstitution Following Autologous Transplantation in Multiple Myeloma.

Don Benson, MD, PhD, Courtney E Bakan, Lana Alghothani, Craig C. Hofmeister, MD, Yvonne A Efebera, M.D., Megan K Smith, MS, CNP, RN, Carli N Greenfield, Pascale Andre, PhD, Patrick Squiban, Francois Romagne, PhD, Michael A. Caligiuri, M.D., Steven M Devine, MD

Blood (2009) 114 (22): 4641.

https://doi.org/10.1182/blood.V114.22.4641.4641

Published: 2009

Journal Articles

Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results.

Don Benson, MD, PhD, Craig C. Hofmeister, MD, Swaminathan Padmanabhan, MD, MBBS, Rafat Abonour, Attaya Suvannasankha, MD, Alain Mita, Patrick Squiban, MD, Megan K Smith, MS, CNP, RN, Courtney E Bakan, Marc Marzetto, Pascale Andre, PhD, Jerome Tollier, Michael A. Caligiuri, M.D., Sherif Farag, MBBS, PhD

Blood (2009) 114 (22): 2880.

https://doi.org/10.1182/blood.V114.22.2880.2880

Published: 2009

Journal Articles

IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody, and Lenalidomide Combine to Enhance the Natural Killer (NK) Cell Versus Multiple Myeloma (MM) Effect.

Don Benson, MD, PhD, Courtney E Bakan, Shuhong Zhang, PhD, Lana Alghothani, Jing Liang, Craig Hofmeister, MD, Shivani Srivastava, MD, Megan K Smith, MS, CNP, RN, Carli N Greenfield, Pascale Andre, PhD, Patrick Squiban, MD, Francois Romagne, PhD, Michael A. Caligiuri, M.D., Sherif Farag, MBBS, PhD

Blood (2009) 114 (22): 3870.

https://doi.org/10.1182/blood.V114.22.3870.3870

Published: 2009

Journal Articles

Phase IIB Trial of Aminopterin in Multiagent Therapy for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) at High Risk of Relapse.

Peter D. Cole, MD, Richard A. Drachtman, MD, Angela K. Smith, Margaret Masterson, MD, John Glod, Md, PhD, Barton A. Kamen, MD, PhD

Blood (2006) 108 (11): 1860.

https://doi.org/10.1182/blood.V108.11.1860.1860

Published: 2006

Journal Articles

Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development

Emma M. K. Smith, Peter Åkerblad, Tom Kadesch, Håkan Axelson, Mikael Sigvardsson

Blood (2005) 106 (6): 1995–2001.

https://doi.org/10.1182/blood-2004-12-4744

Published: 2005

Journal Articles

Aminopterin Can Replace Methotrexate for Children with Newly Diagnosed Acute Lymphoblastic Leukemia without Excessive Toxicity.

Peter D. Cole, MD, Richard A. Drachtman, MD, Margaret Masterson, MD, Angela Shenkerman, APN, Angela K. Smith, Benadette Makori, Barton A. Kamen, MD, PhD

Blood (2004) 104 (11): 1950.

https://doi.org/10.1182/blood.V104.11.1950.1950

Published: 2004

Journal Articles

Increases in Neutral, Mg 2+ -Dependent and Acidic, Mg 2+ -Independent Sphingomyelinase Activities Precede Commitment to Apoptosis and Are Not a Consequence of Caspase 3–Like Activity in Molt-4 Cells in Response to Thymidylate Synthase Inhibition by GW1843

Ronald M. Laethem, Yusuf A. Hannun, Supriya Jayadev, Connie J. Sexton, Jay C. Strum, Rebecca Sundseth, Gary K. Smith

Blood (1998) 91 (11): 4350–4360.

https://doi.org/10.1182/blood.V91.11.4350

Published: 1998

Journal Articles

Quantitative Long-Term Culture-Initiating Cell Assays Require Accessory Cell Depletion That Can Be Achieved by CD34-Enrichment or 5-Fluorouracil Exposure

Manfred R. Koller, Ilana Manchel, Alan K. Smith

Blood (1998) 91 (11): 4056–4064.

https://doi.org/10.1182/blood.V91.11.4056

Published: 1998

Journal Articles

Pharmacokinetics of factor IX [letter]

K Smith

Blood (1986) 68 (4): 979–980.

https://doi.org/10.1182/blood.V68.4.979.979

Published: 1986

NARROW

Inhibition of Endothelial Cell Tube Formation by ADAMTS13 Occurs Via Interaction with VEGF

Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis.

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Characterization of Early Natural Killer Cell Reconstitution Following Autologous Transplantation in Multiple Myeloma.

Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results.

IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody, and Lenalidomide Combine to Enhance the Natural Killer (NK) Cell Versus Multiple Myeloma (MM) Effect.

Phase IIB Trial of Aminopterin in Multiagent Therapy for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) at High Risk of Relapse.

Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development

Aminopterin Can Replace Methotrexate for Children with Newly Diagnosed Acute Lymphoblastic Leukemia without Excessive Toxicity.

Increases in Neutral, Mg 2+ -Dependent and Acidic, Mg 2+ -Independent Sphingomyelinase Activities Precede Commitment to Apoptosis and Are Not a Consequence of Caspase 3–Like Activity in Molt-4 Cells in Response to Thymidylate Synthase Inhibition by GW1843

Quantitative Long-Term Culture-Initiating Cell Assays Require Accessory Cell Depletion That Can Be Achieved by CD34-Enrichment or 5-Fluorouracil Exposure

Pharmacokinetics of factor IX [letter]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only